Catalyst Wire Dossier Catalyst Wire Dossier

BNT331

· BioNTech SE
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BNT331, covering 2025-08-07 to 2025-08-07. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-human Safety Trial of BNT331 Administered as Single Ascending Doses in Healthy Women and as Multiple Ascending Doses in Women Diagnosed With Bacterial Vaginosis [Phase 1]

See pricing